These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 2244610)
1. Impetigo. Current etiology and comparison of penicillin, erythromycin, and cephalexin therapies. Demidovich CW; Wittler RR; Ruff ME; Bass JW; Browning WC Am J Dis Child; 1990 Dec; 144(12):1313-5. PubMed ID: 2244610 [TBL] [Abstract][Full Text] [Related]
2. Treatment of staphylococcal skin infections: a comparison of cephalexin and dicloxacillin. Dillon HC J Am Acad Dermatol; 1983 Feb; 8(2):177-81. PubMed ID: 6826814 [TBL] [Abstract][Full Text] [Related]
3. Impetigo contagiosa: a comparison of erythromycin and dicloxacillin therapy. Barton LL; Friedman AD; Portilla MG Pediatr Dermatol; 1988 May; 5(2):88-91. PubMed ID: 3045781 [TBL] [Abstract][Full Text] [Related]
4. Impetigo: a reassessment of etiology and therapy. Barton LL; Friedman AD Pediatr Dermatol; 1987 Nov; 4(3):185-8. PubMed ID: 3122189 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of impetigo. Coskey RJ; Coskey LA J Am Acad Dermatol; 1987 Jul; 17(1):62-3. PubMed ID: 3611455 [TBL] [Abstract][Full Text] [Related]
6. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy. Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections. Gisby J; Bryant J Antimicrob Agents Chemother; 2000 Feb; 44(2):255-60. PubMed ID: 10639346 [TBL] [Abstract][Full Text] [Related]
8. Is penicillin still the drug of choice for non-bullous impetigo? Feder HM; Abrahamian LM; Grant-Kels JM Lancet; 1991 Sep; 338(8770):803-5. PubMed ID: 1681172 [No Abstract] [Full Text] [Related]
9. Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains. Dagan R; Bar-David Y Antimicrob Agents Chemother; 1992 Feb; 36(2):287-90. PubMed ID: 1605593 [TBL] [Abstract][Full Text] [Related]
10. Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin. Barton LL; Friedman AD; Sharkey AM; Schneller DJ; Swierkosz EM Pediatr Dermatol; 1989 Jun; 6(2):134-8. PubMed ID: 2501775 [TBL] [Abstract][Full Text] [Related]
11. Cephalexin and penicillin in the treatment of group A beta-hemolytic streptococcal throat infections. Disney FA; Dillon H; Blumer JL; Dudding BA; McLinn SE; Nelson DB; Selbst SM Am J Dis Child; 1992 Nov; 146(11):1324-7. PubMed ID: 1415072 [TBL] [Abstract][Full Text] [Related]
12. [Contagious impetigo--pathogen spectrum and therapeutic consequences]. Abeck D; Mempel M; Seidl HP; Schnopp C; Ring J; Heeg K Dtsch Med Wochenschr; 2000 Oct; 125(42):1257-9. PubMed ID: 11098236 [TBL] [Abstract][Full Text] [Related]
18. 50 Years Ago in The Journal of Pediatrics: Erythromycin versus Penicillin for the Treatment of Streptococcal Skin Infections. Long SS J Pediatr; 2020 Oct; 225():29. PubMed ID: 32977867 [No Abstract] [Full Text] [Related]
19. Bacterial skin infections at a tertiary dermatological centre. Tan HH; Tay YK; Goh CL Singapore Med J; 1998 Aug; 39(8):353-6. PubMed ID: 9844495 [TBL] [Abstract][Full Text] [Related]
20. Azithromycin compared with cephalexin in the treatment of skin and skin structure infections. Mallory SB Am J Med; 1991 Sep; 91(3A):36S-39S. PubMed ID: 1656741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]